https://investors.maynepharma.com/activity-updates/PKd0Yy-mayne-pharma-2026-half-year-results-media-release 2026-02-23T02:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/PwW8pP-mayne-pharma-management-changes 2026-02-23T02:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/epj8BP-mayne-pharma-2025-full-year-results-media-release 2025-08-25T03:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/egl8Rr-mayne-pharma-2025-half-year-results-media-release 2025-08-26T03:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/y57Nzr-mayne-pharma-enters-into-a-scheme-implementation-deed-with-cosette-pharmaceuticals-inc 2025-02-21T02:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/rJz7xr-mayne-pharma-2024-full-year-results-media-release 2024-08-23T03:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/PbV88P-mayne-pharma-2024-half-year-results-media-release 2024-02-26T02:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/rD67ly-mayne-pharma-q1-fy24-trading-update 2023-10-19T02:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/yMp75P-mayne-pharma-2023-full-year-results-media-release 2023-09-02T03:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/PG479y-mayne-pharma-investor-update-and-on-market-share-buy-back-program 2023-05-10T03:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/eXo7qy-mayne-pharma-completes-sale-of-u-s-generics-portfolio-to-dr-reddys 2026-07-06T03:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/PQ17zP-mayne-pharma-2023-half-year-results-media-release 2023-04-28T03:00:00Z monthly 0.6 https://investors.maynepharma.com/activity-updates/eNN7Ze-mayne-pharma-announces-sale-of-u-s-generics-portfolio-to-dr-reddys 2023-02-23T02:00:00Z monthly 0.6